Nancy Thornberry - 08 Jan 2022 Form 4 Insider Report for Denali Therapeutics Inc. (DNLI)

Role
Director
Signature
/s/ Tyler Nielsen, by power of attorney
Issuer symbol
DNLI
Transactions as of
08 Jan 2022
Net transactions value
$0
Form type
4
Filing time
11 Jan 2022, 18:54:31 UTC
Previous filing
21 Jun 2021
Next filing
06 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DNLI Common Stock Award $0 +627 +33% $0.000000 2,511 08 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person has reported prior awards of restricted stock units in Table II of Form 4. This total reported in Column 5 includes 1884 previously reported restricted stock units and 627 shares acquired pursuant to vesting of restricted stock units.